| Dr Mark Taylor, MD | |
|
700 Shadow Ln., Suite 240, Las Vegas, NV 89106-4158 | |
| (702) 384-0022 | |
| (702) 384-0529 |
| Full Name | Dr Mark Taylor |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 33 Years |
| Location | 700 Shadow Ln., Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821088857 | NPI | - | NPPES |
| 2018647 | Medicaid | NV | |
| 20-18647 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 10081 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sunrise Hospital And Medical Center | Las vegas, NV | Hospital |
| Valley Hospital Medical Center | Las vegas, NV | Hospital |
| Kingman Regional Medical Center | Kingman, AZ | Hospital |
| Valley View Medical Center | Fort mohave, AZ | Hospital |
| North Vista Hospital | North las vegas, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Heart Center Of Nevada | 0042111825 | 19 |
News Archive
Mental illness associated with early childhood adversity may be passed from generation to generation, according to a study of adults whose parents evacuated Finland as children during World War II.
ERYTECH Pharma SA announced today that it has received clearance of its Investigational New Drug Application from the United States Food and Drug Administration to initiate a Phase I clinical trial of its product ERYASP, L-asparaginase loaded erythrocytes, in patients 40 years or older with newly diagnosed Acute Lymphoblastic Leukemia.
Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT®) and ViiV's Integrase Inhibitor dolutegravir(marketed as TIVICAY®) as the sole active ingredients for the maintenance treatment of people living with Human Immunodeficiency Virus (HIV).
In a new study published in the journal Science Advances a connection was found between friendliness of dogs and a particular genetic makeup. Dogs differ from their closest cousins – wolves, in their friendliness towards humans and the gene that makes this possible has now been uncovered. This gene that allows for the hypersocial behaviour in dogs is also common in humans the study finds.
An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, has now demonstrated the potential to also prolong patient survival.
› Verified 7 days ago
| Entity Name | Heart Center Of Nevada |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063526960 PECOS PAC ID: 0042111825 Enrollment ID: O20040115000436 |
News Archive
Mental illness associated with early childhood adversity may be passed from generation to generation, according to a study of adults whose parents evacuated Finland as children during World War II.
ERYTECH Pharma SA announced today that it has received clearance of its Investigational New Drug Application from the United States Food and Drug Administration to initiate a Phase I clinical trial of its product ERYASP, L-asparaginase loaded erythrocytes, in patients 40 years or older with newly diagnosed Acute Lymphoblastic Leukemia.
Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT®) and ViiV's Integrase Inhibitor dolutegravir(marketed as TIVICAY®) as the sole active ingredients for the maintenance treatment of people living with Human Immunodeficiency Virus (HIV).
In a new study published in the journal Science Advances a connection was found between friendliness of dogs and a particular genetic makeup. Dogs differ from their closest cousins – wolves, in their friendliness towards humans and the gene that makes this possible has now been uncovered. This gene that allows for the hypersocial behaviour in dogs is also common in humans the study finds.
An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, has now demonstrated the potential to also prolong patient survival.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Taylor, MD 700 Shadow Ln., Suite 240, Las Vegas, NV 89106-4158 Ph: (702) 384-0022 | Dr Mark Taylor, MD 700 Shadow Ln., Suite 240, Las Vegas, NV 89106-4158 Ph: (702) 384-0022 |
News Archive
Mental illness associated with early childhood adversity may be passed from generation to generation, according to a study of adults whose parents evacuated Finland as children during World War II.
ERYTECH Pharma SA announced today that it has received clearance of its Investigational New Drug Application from the United States Food and Drug Administration to initiate a Phase I clinical trial of its product ERYASP, L-asparaginase loaded erythrocytes, in patients 40 years or older with newly diagnosed Acute Lymphoblastic Leukemia.
Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT®) and ViiV's Integrase Inhibitor dolutegravir(marketed as TIVICAY®) as the sole active ingredients for the maintenance treatment of people living with Human Immunodeficiency Virus (HIV).
In a new study published in the journal Science Advances a connection was found between friendliness of dogs and a particular genetic makeup. Dogs differ from their closest cousins – wolves, in their friendliness towards humans and the gene that makes this possible has now been uncovered. This gene that allows for the hypersocial behaviour in dogs is also common in humans the study finds.
An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, has now demonstrated the potential to also prolong patient survival.
› Verified 7 days ago
Dr. Arshi A. Quadeer, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2545 S Bruce St Ste 200, Las Vegas, NV 89169 Phone: 702-732-2438 Fax: 702-737-5043 | |
Cherie Lin, D.O. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3006 S Maryland Pkwy, Suite 400, Las Vegas, NV 89109 Phone: 702-369-5582 Fax: 702-369-1533 | |
Michael M Lee, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-921-6823 Fax: 702-549-5240 | |
Henry Palangdao Igid, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 653 N Town Center Dr Ste 402, Las Vegas, NV 89144 Phone: 702-243-7200 Fax: 702-243-7235 | |
Ian Adrian Fanoga Frani, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-383-2000 Fax: 702-383-3875 | |
Sein Tun, DO Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 620 Shadow Ln, Las Vegas, NV 89106 Phone: 702-388-4000 | |
Berge Jack Dadourian, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 400 S Rampart Blvd, Suite 240, Las Vegas, NV 89145 Phone: 702-906-1100 Fax: 702-906-1110 |